Related Experiment Video

Updated: Mar 8, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

The role of MDM2 and MDM4 in breast cancer development and prevention

Sue Haupt1, Reshma Vijayakumaran1,2, Panimaya Jeffreena Miranda1,2

  • 1Tumour Suppression Laboratory, Peter MacCallum Cancer Centre, Melbourne 3000, Australia.

Journal of Molecular Cell Biology
|January 19, 2017
PubMed

Insights

The mouse double minute (MDM) family, including MDM2 and MDM4 proteins, regulates cellular stress responses. Dysregulation of this family is linked to aggressive breast cancer, highlighting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastatic breast cancer, characterized by drug resistance, is a leading cause of mortality.
  • The mouse double minute (MDM) family, comprising MDM2 and MDM4 proteins, plays a crucial role in cellular responses to stress and genomic stability.
  • MDM family proteins are known negative regulators of the tumor suppressor p53, modulating cellular stress responses.

Purpose of the Study:

  • To review recent findings on the role of the MDM family in normal and malignant breast cells.
  • To explore the MDM family as potential therapeutic targets for breast cancer treatment.
  • To understand how MDM family dysregulation contributes to aggressive and drug-resistant breast cancer.

Main Methods:

  • Literature review of recent research on the MDM family in breast cancer.
  • Analysis of the regulatory functions of MDM2 and MDM4 in cellular stress and development.
  • Examination of the association between MDM family protein levels and cancer risk.

Main Results:

  • Elevated MDM family protein levels are strongly associated with increased cancer incidence.
  • The MDM family is critical for normal breast development and maintaining genomic integrity.
  • MDM family dysregulation contributes to aggressive, drug-resistant metastatic breast cancer.

Conclusions:

  • Targeting the MDM family offers a promising avenue for developing tailored breast cancer therapies.
  • Therapeutic strategies must consider the impact on both cancerous and healthy cells.
  • Further research into the MDM family's role in breast cancer is crucial for advancing treatment options.
Keywords:
MDM2MDM4TP53breast cancerp53

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.9K
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

20.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K